Prostate Cancer Metastatic Disease research hub

A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

This study is testing a new drug, HLD-0915, for men with advanced prostate cancer that has stopped responding to standard treatments. It aims to see if the drug is safe and effective in slowing down the cancer's growth.